Gavi's response

Respond and protect: With COVID-19 now reported in almost all Gavi-eligible countries, the Vaccine Alliance is providing immediate funding to health systems, enabling countries to protect health care workers, perform vital surveillance and training, and purchase diagnostic tests.

Maintain, restore and strengthen: Gavi will support countries to adapt and restart immunisation services, rebuild community trust and catch up those who have been missed both before and during the pandemic, while also investing in strengthening immunisation systems to be more resilient and responsive to the communities they serve.

Ensure global equitable access: Gavi is co-leading COVAX, the global effort to securing a global response to COVID-19 that is effective and fair, using its unique expertise to help identify and rapidly accelerate development, production and delivery of COVID-19 vaccines so that anyone that needs them, gets them.

Situation reports

A regular update concerning the impact of and response to the COVID-19 pandemic in Gavi-supported countries.

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines.

Learn more

COVAX Facility

Key news

Scientists around the world are working faster than ever to find vaccines that could stop the spread of COVID-19. Now, nearly a year on since the emergence of this new coronavirus, we have several promising vaccines candidates, one of which has…

Gavi’s long-term approach to developing healthy markets for critical vaccines has led to greater stability and security, providing countries with the confidence that supplies will be available to meet their demand.

In 2019, a higher share of Gavi-supported countries than ever before met their co-financing obligations on time, thanks to strong political commitment.

In 2019, countries delivered more than 230 million routine vaccinations, a record number, supported by unprecedented levels of health system funding from Gavi to support immunisation and protect the most vulnerable children. Here is what Gavi did…

The goal of our market shaping work is to help ensure vaccine markets work better for lower-income countries. We want the maximum number of people to receive the life-saving and health-protecting benefits of immunisation.

After transitioning out of Gavi support in 2017, the Republic of Moldova is mobilising champions and advocates to strengthen vaccine confidence – which is crucial to the success and sustainability of immunisation programmes.

Typhoid fever is increasingly resistant to the main antibiotics used to treat it. Gavi is supporting a new vaccine to help control this deadly disease – and fight antimicrobial resistance.

September 2020 marks the 75th anniversary of the United Nations General Assembly (UNGA). This year, the focus of the high-level General Debate is the importance of effective multilateralism.

Snapshots from DRC, India and Zambia illustrate country ownership and progress in the fights against Ebola, polio and HPV.

COVID-19 explored

View all

Young volunteers gain new skills and give back to their communities.

New variants will push the number needed to reach herd immunity up.

New variants of the coronavirus are causing alarm across the UK and South Africa, with many countries closing their borders to travellers from these countries. But what effect could new strains have on our ability to control the pandemic?

Western Equatoria Ministry of Health and UNICEF are preparing for COVID-19 vaccination campaigns.

How two effective vaccines on the market make it so much harder to quickly test any competing vaccines.

Last updated: 2 Dec 2020

Subscribe to our newsletter